Dupixent 200 MG/1.14 ML pen 1.14ML
Ended Awarded
- Contract number
- SPE2DB25FR2MG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,659
Award facts
- Contract value 100% obligated
- $23,659.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Dupixent (dupilumab) 200 mg/1.14 mL pen injectors, valued at $23,659.28. This competitively awarded, firm fixed-price delivery order is classified as a child contract and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of May 9, 2025. The contract involves no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to compete successfully in federal pharmaceutical procurement markets.
This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime vehicle enables AmerisourceBergen to serve as a critical pharmaceutical supplier for military and federal healthcare systems worldwide, encompassing a comprehensive range of brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical supplies across multiple therapeutic domains. Through this structure, AmerisourceBergen supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare customers, positioning the company as a major vendor within the Defense Logistics Agency's Medical Supply Chain operations.
Quick answers
Who was awarded contract SPE2DB25FR2MG?
SPE2DB25FR2MG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 8, 2025.
How much is contract SPE2DB25FR2MG worth?
The government has obligated $23,659 on SPE2DB25FR2MG.
Is contract SPE2DB25FR2MG an order under another contract?
Yes. SPE2DB25FR2MG is a delivery order under SPE2DB22D2218, an indefinite delivery contract.
Was contract SPE2DB25FR2MG competed?
The extent of competition for SPE2DB25FR2MG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award